Prevalence of CYP2C19 phenotypes in patients undergoing a hiatal hernia repair
{{output}}
Objectives: Gastroesophageal reflux disease is primarily treated with proton pump inhibitors (PPIs), which are metabolized by cytochrome P450 2C19 (CYP2C19) in the liver. CYP2C19 polymorphisms affect PPI plasma levels, with rapid... ...
